Brian Bruen
About Brian Bruen
Brian Bruen is a Lecturer at The George Washington University and a Senior Public Health Research Analyst at RTI International, with over 20 years of experience in public health and policy analysis. His expertise includes pharmaceutical benefit programs and he is dedicated to teaching and mentoring future leaders in the field.
Work at The George Washington University
Brian Bruen has been a Lecturer at The George Washington University since 2019. He previously served as Lead Research Scientist at the same institution from 2009 to 2019. In his current role, he focuses on teaching and mentoring students, aiming to develop future leaders in public health and health policy. His extensive experience in research and policy analysis informs his teaching approach.
Education and Expertise
Brian Bruen holds a Doctor of Philosophy (Ph.D.) in Public Policy and Public Administration from The George Washington University, which he completed from 2011 to 2019. He also earned a Master's degree in Public Policy Analysis from the University of Rochester, where he studied from 1994 to 1996. His undergraduate education includes a Bachelor's degree in Political Science and Government from the University of Rochester, completed from 1991 to 1995.
Background
Brian Bruen has over 20 years of experience in public health care programs, including Medicaid and Medicare. His career includes roles at various organizations, such as the Urban Institute, where he worked as a Research Associate from 1996 to 2004, and the National Association of Chain Drug Stores, where he served as Director of Policy Studies & Research from 2004 to 2007. He also worked at Avalere Health as a Senior Manager from 2007 to 2009 and is currently a Senior Public Health Research Analyst at RTI International.
Achievements
Brian Bruen possesses a broad perspective on pharmaceutical benefit issues, drawing from his experiences with retail pharmacies, pharmaceutical manufacturers, insurers, and patient advocates. He has a keen interest in pharmaceutical benefit programs, particularly factors influencing pharmaceutical use, pricing, and reimbursement. His data analysis skills, combined with strong writing and verbal communication abilities, enable him to effectively bridge gaps between data and policy professionals.